The Department of Oncology was established in 1976. It is the most professional cancer prevention, diagnosis, treatment and follow-up center in Wuxi and has the largest tumor specimen bank in southern Jiangsu. It has a Department of Medical Oncology and a Department of Radiotherapy Oncology (three specialties: head and neck, chest, and abdomen). It has a comprehensive treatment system that integrates radiotherapy, chemotherapy, interventional therapy, integrated traditional Chinese and Western medicine, hyperthermia, biological immunity, genes and other treatment methods, which is conducive to Clinically, individual treatment plans are selected for cancer patients and the efficacy is judged. It enjoys a high reputation in Jiangsu, Wuxi, Changzhou and even inside and outside Jiangsu Province, and has brought good news to tens of thousands of cancer patients.
Technologies such as three-dimensional conformal intensity modulated tumor radiotherapy, intraoperative radiotherapy, DC-CIK cell immunotherapy, and gene therapy have reached the domestic advanced level. Radiating to the entire southern and northern Jiangsu regions, the annual number of cancer patients treated accounts for nearly 50% of the total number of patients in the hospital, and the overall tumor cure and improvement rate reaches 82%. The development of tumor marker detection projects has laid the foundation for early detection and treatment of gastric cancer, lung cancer, intestinal tumors, gynecological tumors and liver cancer, improving the survival rate of tumor patients and reducing treatment costs. It has undertaken a number of provincial and municipal scientific research projects and achieved good clinical results. The cardiothoracic surgery disease diagnosis and treatment specialty in Wuxi is at the leading level in the province. It is also the cardiothoracic surgery treatment center in Wuxi and has been rated as a provincial key clinical specialty. It consists of three secondary specialties: Cardiothoracic Surgery I, Cardiothoracic Surgery II, and Cardiothoracic Surgery III, covering heart, mediastinal, vascular, esophageal, cardiac and general thoracic surgery.
Heart transplantation, beating heart coronary artery bypass grafting, heart valve replacement, various types of congenital heart disease correction, congenital heart disease correction in underweight infants and young children, aortic and large vessel surgery, esophageal surgery, etc. Cardiac, lung, mediastinal tumors and other cardiothoracic surgeries have been performed in more than 10,000 cases, with a success rate of over 98%. The surgical resection rate and five-year survival rate have reached the domestic advanced level. Using thoracoscopy, minimally invasive small incision correction of congenital heart disease and small incision treatment of lung diseases have been achieved, and good results have been achieved. The department was established in June 1976 and is a secondary specialty of the city's key specialty of thoracic and cardiac surgery. There are currently 15 medical staff, 3 people with professional titles of deputy chief physician or above, 2 tutors for master's students, 2 people with master's degrees, 19 open beds, and more than 100 surgeries per year. The current subject leader, Professor Zhou Yunqian, has been engaged in surgical cardiac surgery for more than 30 years. He has accumulated rich experience in the diagnosis and treatment of congenital heart disease, valvular disease, and large vessel surgery, and is especially good at coronary artery surgery.
The undergraduate department has the world's most advanced stoke artificial heart-lung machine, ventilator, and ECG monitoring machine. It is good at treating various congenital heart diseases, rheumatic heart disease, coronary heart disease, and various aortic diseases. 4 cases of orthotopic allogeneic heart transplantation were performed. It was the first in the province to carry out minimally invasive technology to treat congenital heart disease, with a success rate of 99% and a cure rate of 97%. Won 5 provincial and municipal new technology introduction awards. The Department of Neurosurgery was established in the early 1980s as a training center for master's students of Soochow University School of Medicine. It currently has more than ten medical staff, including 2 deputy chief physicians, 20 open beds, equipped with specialized ICU wards, and an annual operation volume of 200 cases.
The department is the first to carry out functional neurosurgery stereotactic surgery and frameless navigation brain tumor surgery in the city, filling the gaps in the city. It has accumulated rich experience in the treatment of various types of craniocerebral injuries, hypertensive cerebral hemorrhage, and surgical treatment of intracranial tumors. The surgical success rate and postoperative quality of life are both in a leading position in the province. The Department of Urology is a comprehensive department that integrates medical care, teaching, and scientific research. It is especially in a leading position in the treatment of various tumors. In 1991, the Department of Urology launched intraoperative radiotherapy for bladder cancer, which allowed patients to retain the normal urinary function of the bladder and avoid the inconvenience caused by total cystectomy. This technology is leading in the country and has been awarded by Wuxi City and Jiangsu Provincial Health. The second prize of the Department of Science and Technology Progress Award. The development of this surgical method provides an ideal treatment plan for advanced bladder cancer, especially for elderly patients who have bladder cancer and cannot undergo total resection. Urethral-preserving prostate enucleation (Madigen surgery) won the second prize of Science and Technology Progress Award from Wuxi Municipal Health Bureau in 1995. Spiral CT urinary system imaging technology is painless for patients and has good examination results. Won the second prize for new technology introduction from the Jiangsu Provincial Department of Health.
In 1985, the most advanced transurethral endoscopic resection equipment was introduced from abroad. It was the first hospital in Wuxi to perform this surgery. This treatment method requires no incision, has short operation time, less bleeding and is painless. , fast recovery and other advantages.
The new generation of intracavitary surgical equipment "Suspended Ion Knife" has more advantages for prostate resection, bladder tumor resection, female bladder neck obstruction incision, and urethral stricture incision. Transurethral endoscopic bladder neck sling surgery for female stress urinary incontinence has reached the same level as domestic tertiary hospitals. In addition to surgery, comprehensive comprehensive treatment methods such as radiotherapy, chemotherapy, and intervention are also carried out for various tumors in urological and reproductive surgery (adrenal pheochromocytoma, kidney cancer, adrenal tumors, bladder cancer, prostate cancer, etc.). It has unique advantages in the treatment of malignant tumors. Extracorporeal shock wave lithotripsy has achieved good results in treating urinary system stones. Carry out the treatment of various urinary system tumors, congenital malformations and other diseases in pediatric urology. Carry out laparoscopic resection of kidney tumors, adrenal tumors, renal cysts, etc. He has rich clinical experience in the diagnosis and treatment of male diseases, prostatitis, female urinary dysfunction and other diseases.
The Department of Orthopedics was established in 1976. After more than 30 years of hard development, it has become a department with complete equipment, strong technical force, vitality, strong team fighting capacity, and a certain reputation in Wuxi City.
The Department of Orthopedics currently has a ward with 48 open beds and more than 20 medical staff. Among them, there are 7 doctors, 2 with senior professional titles, 1 chief physician, professor, and master's tutor, 1 deputy chief physician, associate professor, and 4 attending doctors, including 3 master's students. The department has MRI, CT, large-scale Philips C-arm machines, SKYER arthroscopes, pivot model intervertebral disc mirrors, orthopedic automatic traction beds, shoulder joint and knee joint CPM functional exercise instruments, bone trauma treatment instruments and other equipment.
The Department of Orthopedics has an annual inpatient capacity of 1,200 and performs 1,000 operations annually. It provides surgical treatment for patients with bone and joint trauma, bone diseases, and bone and soft tissue tumors. The specialty surgeries performed include: minimally invasive surgical treatment of bones and joints (closed reduction and interlocking intramedullary nail fixation, intra-articular fracture reduction and fixation under arthroscopic monitoring), cervical spondylosis discectomy and vertebral body fusion, and subtotal vertebral body resection and fusion. Surgery, cervical disc replacement, multi-segment spinal stenosis, posterior single-door surgery, lumbar instability, anterior and posterior pedicle fusion, lumbar disc herniation, microscopic disc nucleectomy, ultra-high-dose chemotherapy for malignant bone tumors of extremities Limb salvage surgery, full-width, total knee replacement, revision surgery, pelvic tumor resection and hemipelvic replacement, and target vessel embolization of huge sacrococcygeal tumors. The department not only focuses on clinical treatment, but also actively carries out scientific research and has achieved a number of results: among them, clinical research on three-dimensional external fixation of pelvic fractures and clinical research on limb-salvage surgery with ultra-high-dose chemotherapy for osteosarcoma in the extremities, both of which have passed expert appraisal. And achieved good social and economic benefits. The clinical research on target vessel embolization for sacrococcygeal giant tumor resection won the second prize of the Municipal Science and Technology Introduction Award. The topics carried out include: clinical research on minimally invasive treatment of spinal metastatic tumors; clinical research on regional infusion chemotherapy under extracorporeal circulation for malignant bone tumors in extremities. The respiratory department has 40 approved beds and 46 beds are actually open. It consists of a Respiratory Intensive Care Unit (RICU) and a fiberoptic bronchoscopy room. There are currently 7 specialists, including 1 chief physician, 1 deputy chief physician, 3 attending physicians and 2 resident physicians. It has 10 sets (sets) of medical equipment worth more than 10,000 yuan, including 2 sets of Japanese Olympus fiber bronchoscopes, 1 German Jaeger pulmonary function meter, 4 imported ventilators, 1 endoscopic microwave therapy instrument, and multi-functional monitoring 2 instruments.
Use a variety of methods to diagnose lung cancer before surgery, chemoradiotherapy, treat primary or metastatic lung cancer under fiber bronchoscopy, use tracheal stents to treat tracheal stenosis or tracheo-esophageal fistula caused by lung cancer, and use transbronchial needles Suction biopsy, removal of foreign bodies under fiberoptic bronchoscopy, mechanical ventilation treatment of respiratory failure, severe pulmonary infection, diagnosis and thrombolysis of pulmonary embolism, anticoagulation treatment, diagnosis and treatment of interstitial lung disease, radiation pneumonitis, etc. are all the advantages of the respiratory department. .
Routinely performed diagnosis and treatment items include percutaneous lung puncture under CT or B-ultrasound guidance, pleural biopsy, invasive and non-invasive mechanical ventilation to treat respiratory failure, fiberoptic bronchoscopy, bronchoalveolar lavage, transfibrous bronchoscopy Microscopic high-frequency electrosurgical surgery, tracheal microwave endotracheal tumor ablation, tracheal stent implantation, transbronchial needle aspiration, bronchial arterial perfusion, embolization, pulmonary residual air, diffusion function measurement, bronchodilation test, etc. There are currently 30 medical staff, including 5 deputy senior staff or above, 5 with master's degree or above (including PhD), and 1 master's student supervisor. It has 50 open beds and consists of two secondary departments: neonatology and pediatric internal medicine. The annual outpatient volume is about 60,000, and the hospital treats more than 2,000 inpatients annually.
Neonatology Department
It has 2 associate senior staff or above, 1 doctorate, 12 open beds, HILL-ROM high-end imported infant incubator, Servo-i high-end imported pediatric incubator Ventilators and intensive care units have successfully treated a large number of severe and difficult cases, with a rescue success rate of 95%. It was the first in the city to successfully carry out mechanical ventilation for very low birth weight infants, pulmonary surfactant to prevent and treat neonatal respiratory distress syndrome, and neonatal liver puncture. "Pulmonary Surfactant Technology to Prevent and Treat Neonatal RDS under Mechanical Ventilation" won the 2005 Wuxi City Award The Health Bureau won the first prize for the introduction of new technologies and new projects, and the cases of congenital hepatoblastoma and congenital rubella syndrome treated were published in journals such as "Chinese Journal of Pediatrics".
Pediatric Internal Medicine
Features pediatric cardiovascular, pediatric endocrinology and pediatric respiratory specialties. It has 3 associate senior staff or above, 3 people with master's degree, and 38 open beds.